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Abstract
Purpose: To improve microscopic evaluation of im-
mune cells relevant in breast cancer oncoimmunology,
we aim at distinguishing normal infiltration patterns
from lymphocytic lobulitis by advanced image analy-
sis. We consider potential immune cell variations due
to the menstrual cycle and oral contraceptives in non-
neoplastic mammary gland tissue.
Methods: Lymphocyte and macrophage distribu-
tions were analyzed in the anatomical context of the
resting mammary gland in immunohistochemically stained
digital whole slide images obtained from 53 reduction
mammoplasty specimens. Our image analysis workflow
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included automated regions of interest detection, im-
mune cell recognition, and co-registration of regions of
interest.
Results: In normal lobular epithelium, seven CD8+
lymphocytes per 100 epithelial cells were present on av-
erage and about 70% of this T-lymphocyte population
was lined up along the basal cell layer in close prox-
imity to the epithelium. The density of CD8+ T-cell
was 1.6 fold higher in the luteal than in the follicular
phase in spontaneous menstrual cycles and 1.4 fold in-
creased under influence of oral contraceptives, and not
co-localized with epithelial proliferation. CD4+ T-cells
were infrequent. Abundant CD163+ macrophages were
widely spread, including the interstitial compartment,
with minor variation during the menstrual cycle.
Conclusions: Spatial patterns of different immune
cell subtypes determine the range of normal, as opposed
to inflammatory conditions of the breast tissue microen-
vironment. Advanced image analysis enables quantifi-
cation of hormonal effects, refines lymphocytic lobulitis,
and shows potential for comprehensive biopsy evalua-
tion in oncoimmunology.
Keywords lymphocytic lobulitis · digital pathology ·
oncoimmunology · object-based image analysis ·
menstrual cycle · hormonal fluctuations
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1 Introduction
Lymphocytic lobulitis (LLO) is an inflammatory con-
dition previously observed in normal breast tissue [8],
autoimmune disease [24,38], nonmalignant mammary
glands from patients with germline BRCA1/2 muta-
tions [19], and as peritumoral phenomenon in breast
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cancer [7,25,11]. So far, LLO has mainly been described
by absolute immune cell numbers per lobule of the mam-
mary gland [7,25,19,16,8]. While the reported descrip-
tions that rely solely on estimated cell counts have cap-
tured important features of LLO, there remains some
degree of uncertainty. The anatomical term “lobule”
as a reference area can be readily identified, but size,
shape, and cellular content of cross sections at differ-
ent levels can be highly variable. Further, individual
observers may consider different structures as “repre-
sentative lobules”. Moreover, the potential influence of
hormonal fluctuations on immune cell infiltrates has not
yet been considered. Therefore, it cannot be excluded
that current definitions of LLO may miss important as-
pects of the dynamic temporal or spatial inflammatory
tissue microenvironment (iTME) variability.
Previously, we developed context-related immune
cell evaluation in single microscopic images [22], im-
proved color deconvolution in digital whole slide im-
ages (WSIs) [42], and automated detection of lobular
structures adjacent to tumors [15].
In this study, we implemented an advanced digital
image analysis workflow specifically adjusted to iTME
in breast tissue to characterize the range of normal im-
mune presence in the healthy breast tissue and distin-
guish normal, potentially fluctuating immune surveil-
lance from pathological conditions. We consider LLO
as a use case for comprehensive evaluation of iTME in
an anatomically well-defined context with clinical rel-
evance. This addresses the emerging challenge of com-
prehensive immune cell evaluation in the era of oncoim-
munology and paves the way for computer-aided breast
cancer biopsy analysis. Therefore, we acquired large-
scale spatial data on immune cells in WSIs by com-
bining novel technologies [3,36] in a modular approach
in breast tissue of healthy women who underwent re-
duction mammoplasty and relate the image-based data
with the hormonal status of the patients at time of
surgery.
2 Materials and Methods
2.1 Tissue samples
Breast tissue was obtained from 53 premenopausal healthy
women who underwent reduction mammoplasty and
provided a detailed reproductive clinical history [12,13,
1]. 20 women were taking oral contraceptives at time
of surgery (Table 1). The phase of the menstrual cycle
at the day of the surgical procedure was determined
by documentation of the periods prior and after opera-
tion (details in Section 1.1.1 of the Online Resource 1).
One tissue block (one slide per staining) was evaluated
from 47 patients. An additional block was used in six
cases, resulting in a total number of 59 evaluated paraf-
fin blocks. An overview of the evaluated tissue area is
provided in Table 2.
Tissue samples were collected during the surgery
and processed immediately after, fixed in 4% phosphate-
buffered formaldehyde for 24 hours, embedded in paraf-
fin, and cut into 3 µm thick sections. The histopatho-
logical work-up included Haematoxylin-eosin (H&E),
estrogen and progesterone receptors (ER/PR), Cytok-
eratin 5/14, and Ki-67 immunohistochemical stainings
according to automated standard protocols (Ventana
Benchmark Ultra, Tucson, AZ). Immunohistochemistry
for CD8 (Dako M7103), CD4 (Zytomed Systems 503–
3354), CD163 (medac diagnostika 163M–16), and du-
plex staining for CD3/CD20 (CD3: abcam ab52959,
CD20: DAKO M0755) was performed using red and
brown chromogenic labeling provided by Ventana.
A single representative block of the series was used
for the 3D-reconstruction and robustness testing that
addressed the variability of lobular structures and the
concordance of immune cell evaluation across multi-
ple sectioning levels (see Section 3.1). For this pur-
pose, the entire block was sectioned into 3 µm thick se-
rial sections. The first 270 levels were stained for H&E
and used for 3D histology reconstruction, and subse-
quent 100 sections were processed in 10 sets (of 10 sec-
tions each) of which the initial 6 consecutive slides were
stained for CD8/p63 (CD8: Dako M7103, p63: medac
diagnostica Z2003L).
Negative controls were treated identically, but omit-
ting the primary antibody or replacing it by nonim-
mune sera of the same species. WSIs were acquired
by Aperio AT2 scanner (Leica Microsystems, Wetzlar,
Germany) at 40x magnification (resolution 0.253 µm /
pixel).
2.2 Image Analysis
The image analysis concept was focused on two aspects
of immune cell evaluation where computer-assisted ap-
proaches provide an added value over visual inspec-
tion: (1) concordance testing of multiple sectioning lev-
els across a block, and (2) evaluation of automatically
detected ROIs, complementing the established practice
of manually selecting representative fields for evalua-
tion. This ROI detection approach enables expansion
of the evaluated area, standardization of scoring crite-
ria, and streamlining of the analysis process. The first
aspect was addressed by a three-dimensional (3D) his-
tology reconstruction of serial H&E sections, performed
using the Voloom software (microDimensions, Munich,
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Table 1 Composition of the reduction mammoplasty patient cohort and menstrual cycle phases. (*): for 5 patients
in the luteal and 2 patients in the follicular phase of natural cycles (without oral contraceptives), the assignment to a cycle
phase was a “best guess”-approximation due to reportedly irregular menses, (**): parity unknown for 1 patient
Cycle phase
Number of Age at surgery Oral contra- Percentage
patients Median Range ceptive nullipara
luteal
20* 29 21–53 no 35%
9 27 18–34 yes 37.5%**
mid cycle
4 28 21–45 no 75%
4 27 22–32 yes 100%
follicular
9* 29 26–48 no 55.6%
7 26 19–29 yes 85.7%
Table 2 Total size of evaluated lobular area within the breast tissue (in cm2) per patient after automated detection
[3] and quality assessment of ROIs. “StdDev” = standard deviation. The last column (“Multiple blocks”) shows the range and
the median (in brackets) for the six patients for which two blocks were considered (see Section 2.1).
Staining Range Median Mean StdDev Multiple blocks
Ki-67 0.02–2.74 0.72 0.88 0.70 0.36–2.74 (1.18)
CD8 0.06–3.68 0.78 0.92 0.72 0.36–1.48 (1.10)
CD4 0.06–2.16 0.74 0.86 0.56 0.38–1.60 (1.08)
CD163 0.06–2.74 0.74 0.86 0.62 0.38–1.72 (0.92)
CD3/CD20 0.06–2.76 0.78 0.92 0.70 0.32–2.76 (0.86)
Germany) in one out of the 53 clinically annotated cases
(follicular cycle phase; on oral contraceptives). This was
done in order to analyze how variable size, shape, and
immune cell content of lobular areas considered as “rep-
resentative lobules” can be across multiple consecutive
sectioning levels.
The second aspect was addressed by an approach
resembling and expanding the established practice of
analyzing single sections: The analysis allowed includ-
ing all evaluable lobular areas in a WSI, provided that
they can be automatically detected in an individual
stained section applying reproducible and adaptable
criteria (e.g., minimal accepted size). A quality assur-
ance step ensured exclusion of technically insufficient or
tangentially sectioned small parts of lobules. In order
to quantify immune cell numbers in lobular structures,
we developed a modular workflow (see Fig. 1), com-
bining automated regions of interest (ROIs) detection
[3], high-resolution cell detection with a robust analysis
module for nucleus detection (part of the Tissue Phe-
nomics framework, Definiens AG, Munich, Germany)
[5], and subsequent cell classification. For quality con-
trol, all automatically detected ROIs were verified by
visual inspection of an expert. All correctly detected
lobular areas (Table 2 of the Online Resource 1) were
used for statistical analysis.
Detected cells were grouped into immune cells, posi-
tively stained with respective lineage markers, and neg-
atively stained cells. The latter were further distinguished
into epithelial cells and other (e.g., stromal) elements
based on morphological features. The approach for Ki-
67 staining was adjusted considering that this marker is
not cell lineage-specific. Based on published evidence of
relevant distances for cytotoxic effector functions and
chemokine mediated cell-cell communication [20], we
classified each stained immune cell into one of three
categories as “in contact with an epithelial cell” (no dis-
tance to the closest epithelial cell), “short distance to
an epithelial cell” (distance to the closest epithelial cell
less than two average cell diameters enabling communi-
cation via chemokines), and “in lobular stroma” (within
lobular area but chemokine gradient sensing could not
be possible [27,28]).
To investigate co-localization between different im-
munohistochemical markers, we applied existing co-registration
methods [43,4,37,36] to allow quantitative evaluation
of corresponding regions. To enable full individual anal-
ysis of every separate slide, ROIs were individually iden-
tified [3] and corresponding areas for joint analysis were
defined as overlapping regions (Fig. 1 of the Online
Resource 1). This approach addressed a challenge fre-
quently faced in object-based biomarker analyses with
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Whole slide images
Manual annotationsNuclei detection by De niens [17]
Texture-based classi cation [12]Manual quality control
Segmented cells
Regions o nterest
Combination
Epithelial compartment Di!erent cell types
Statistical analysis
Fig. 1 Flow chart of image analysis process: A texture and machine learning based region classification detects the region
of interests [3] and a Definiens software module was used to segment the nuclei [5]. Based on color information and spatial
distances, the nuclei in regions of interest were classified into different cell types
multiple immunohistochemical staining methods, where
the sectioning levels show corresponding tissue regions
but may not exactly match in subsequent sections.
2.3 Statistical considerations
Due to the strongly varying size of automatically de-
tected lobular areas, immune cell counts as well as the
amount of Ki-67+ cells were normalized by the num-
ber of epithelial cells. Comparisons between subgroups
were performed using a nonparametric test (Wilcoxon–
Mann–Whitney) with accepted significance level α of
0.001. A detailed description of the statistical analy-
sis and the definition of the menstrual cycle phases is
provided in the Online Resource 1.
3 Results
3.1 Robustness of immune cell evaluation across
multiple sectioning levels
The 3D histology reconstruction of breast glandular tis-
sue (Fig. 2 a) confirmed that lobular structures can
vary considerably across different sectioning levels. This
supported the notion that a quantitatively defined ref-
erence unit complementing the descriptive term “lob-
ule” is useful and that specifying objective criteria of
epithelial areas for quantification increases robustness.
Automatically detected lobular areas including about
200–300 epithelial cells were most consistent with the
lower range of “lobule” cross-sections selected for anal-
ysis by pathologists (Fig. 2 b–e). Therefore, we set our
threshold for minimal size of tangentially sectioned lob-
ular structures to 250 epithelial cells, thereby defining
ROIs considered for large-scale automated image anal-
ysis.
In addition, the immune-epithelial cell ratio (IC/EC)
greatly improved robustness of the analysis compared
to only immune cell counts per lobule. Serial sections
of duplex staining quantifying the basal epithelial cells
(p63) in combination with CD8 (Fig. 2 f) showed that
corresponding ROIs in consecutive sections greatly vary
in their epithelial cell content (Fig. 3, left y-axis, series
of strongly dotted diamonds). In contrast, their nor-
malized immune cell density (CD8/p63) remained rela-
tively constant, independently of lobular size, shape,
and epithelial cell content (Fig. 3, left y-axis, series
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Fig. 2 Systematic evaluation of morphological variation across multiple sectioning levels. A 3D histology reconstruction of
mammary gland tissue in multiple consecutive sections confirmed lobular areas strongly varying in shape and size across
consecutive slides. a: 3D-view of the whole tissue block depicting the complexity of the glandular structure. b–e: Different
levels showing how a “lobular area” develops from a single lobule (a) to an epithelial area composed of two lobules (b and
c, white arrows indicate the second lobule), up to an area including a tangential section of a third lobule (asterisk), together
composing a lobular ROI (oval blue outline). f : Consecutive 3 µm thick immunohistochemistry slides, shown a CD8 (brown)
and p63 (red) duplex stain with hematoxilin counterstain. Note the considerable variation in shape and size of the lobular
components, including a shrinkage artifact in the third image (arrow)
of faintly dotted points). Taken together, these results
showed that robustness of iTME evaluation can be im-
proved by careful definition of evaluable ROIs and ap-
propriate normalization of immune cell counts. Given
that immune cell scoring requires consideration of vari-
ation between sectioning levels even in an anatomically
well-defined healthy glandular structure, we anticipate
that the iTME evaluation in much more heterogeneous
and poorly differentiated tumor samples will hugely
benefit from our image analysis workflow.
3.2 Variable lymphocyte patterns in different phases
of the menstrual cycle
Immune cell infiltration in the normal breast tissue was
variable and associated with the menstrual cycle. We
observed a heterogeneous occurrence of immune cells
within tissue samples of an individual and between pa-
tients. This was consistent with our previous results
in a subset of the present series, recently described in
[1]. In general, there was a high number of CD8+ T-
lymphocytes, about seven per 100 epithelial cells on
average. The overall mean density of CD8+ T-cells was
significantly higher in the luteal than in the follicular
phase of the menstrual cycle with 1.6 fold increase in
patients not taking oral contraceptives (p < 0.001) and
1.4 fold increase (p < 0.001) in patients taking oral con-
traceptives (Fig. 4). This difference was predominantly
driven by the CD8+ lymphocytes in close contact to
the epithelial layer and less evident in the stromal in-
filtrates. The presence of potentially cytotoxic CD8+
T-cells in direct contact with morphologically vital ep-
ithelial cells suggested an inactive or resting functional
state, consistent with a presumable role in continuous
immunosurveillance. Further, in patients using oral con-
traceptive, the CD8+ density was 1.1 fold higher re-
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Fig. 3 Robustness of the ratio between CD8+ T-cells and p63+ basal epithelial cells in corresponding lobular areas of different
size and shape in consecutive slides. Shown are three (more in Fig. 2 of the Online Resource 1) independent ROIs (different
colors) in a single block of a patient who underwent reduction mammoplasty. Each dark diamond reflects an absolute p63+
basal epithelial cells count (left y-axis) and each light circle of the same color represents the CD8/p63 ratio (right y-axis) in
the same ROI. Some lobular areas remained relatively constant across multiple sections (second row), whereas others changed
in epithelial cell number (first and third row)
gardless of the cycle phase and 1.2 fold higher in the
follicular phase than in patients not taking oral con-
traceptives. In contrast, the overall amount of CD4+
T-helper cells was too small in the normal breast tissue
(on average, about one CD4+ T-cells per 100 epithe-
lial cells; see Fig. 3 of the Online Resource 1) to ana-
lyze their dependence on the menstrual cycle. CD20+
B-lymphocytes were also present, mostly at low num-
bers (on average, less than one B-cell per 100 epithelial
cells), with the only exception of two cases where we ob-
served focally higher densities of CD20+ cells in stromal
localization (Fig. 4 of the Online Resource 1).
3.3 Variation of CD163+ macrophages during the
menstrual cycle
CD163+ macrophages were present in high numbers,
comparable with the amount of CD8+ T-lymphocytes
(Fig. 5 of the Online Resource 1). The density of CD163+
macrophages was significantly lower in the luteal than
in the follicular phase (Table 1 of the Online Resource 1).
In contrast to CD8+ lymphocytes, macrophages were
not obviously co-localized with the epithelial cells. CD163+
macrophage numbers were 1.1 fold increased in patients
taking oral contraceptive compared to patients not tak-
ing oral contraceptive (significant). The spatial distri-
bution of macrophages suggested less contact with in-
dividual epithelial cells than in the case of CD8+ T-
lymphocytes. This might indicate that CD163+ macrophages
have a role in permanent maintenance of the tissue mi-
croenvironment including stromal areas.
3.4 CD8+ lymphocytes in context of epithelial
proliferation
Given that CD8+ lymphocytes were more frequent in
the menstrual cycle phase for which higher rates of pro-
liferation had been previously described [13,41,34], we
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Fig. 4 Differences between follicular and luteal cycle phase in the number of CD8+ T-cells in contact with epithelial
cells (ICIC), close to epithelial cells (ICC), and in lobular stroma (ICIS) displayed as ratio per epithelial cells (IC/EC) in the
same lobule. Shown are the distribution, mean value, upper and lower quantile, as well as the standard deviation. The figure
compares patients without taking oral contraceptives (top row) and patients taking oral contraceptive (bottom row). Dashed
lines illustrate the average values of total immune cell count (i.e., ICIC + ICC + ICIS) over all ROIs (see Table 2 of the Online
Resource 1) in the follicular (red) and luteal (blue) phases
analyzed whether focal peaks in epithelial cell turnover
were co-localized with higher density of immune cells.
Our results (Fig. 6 of the Online Resource 1) for nu-
clear Ki-67 staining were in agreement with published
data, showing that proliferation is generally increased
in the luteal phase [31]. Taking into account that this
increase is especially strong in the second part of the
luteal phase [2], we split this phase in two parts for more
precise statistical analysis (see Online Resource 1). Co-
registration results between CD8 and Ki-67 stained sec-
tions showed that CD8+ lymphocytic infiltrates were
not co-localized with peaks of epithelial proliferation
(correlation coefficient: 0.030). A visual inspection by a
pathologist of several images confirmed the accuracy of
this automated analysis result, as shown in the repre-
sentative examples of Fig. 5.
Assuming that increased cell turnover is associated
with elevated risk for cell damage or aberrant cell di-
visions [29,23], it would be plausible that CD8+ cells
could possibly be required in higher numbers close to
areas of transient proliferative activity, such that a co-
localization with areas of increased cell renewal in the
luteal phase [33,30] could be expected. However, our
results do not support this expectation and may indi-
cate that the majority of CD8+ cells are not actively
involved in processes associated with local or tempo-
ral peaks of epithelial cell turnover, consistent with a
resting functional state.
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a (Ki-67) b (CD8)
c (Ki-67) d (CD8)
e (Ki-67) f (CD8)
Fig. 5 a–b: ROI with high Ki-67 (left) and high CD8 (right) level. c–d: ROI with high Ki-67 (left) and low CD8 (right) level.
e–f : ROI with low Ki-67 (left) and high CD8 (right) level
3.5 Spatial distribution of immune cells in normal
breast
A comprehensive repository of the spatial distribution
of immune cells in normal breast tissue, confirmed by
image analysis, could serve as a reference to distinguish
pathological conditions from normal immunosurveillance.
As a major step towards such a reference data base, our
workflow captured spatial aspects such as stromal local-
ization of immune cells and provided the technological
prerequisites to combine measures for lymphocyte sub-
sets such as local CD4/CD8 evaluation in previously
defined ROIs. CD8+ T-cells were surprisingly abundant
in normal breast tissue, predominantly localized in di-
rect contact to epithelial cells (p < 0.001), and appeared
to vary under hormonal influence. Differently from this
distribution pattern, CD4+ T-cells were rare and in dif-
fuse localization, and CD163+ macrophages occurred
abundantly and widely spread. We propose integrating
such quantitative and spatial aspects in future defini-
tions of LLO. As one example for such combined spatial
patterns, the two single lobules that were identified as
“outliers” with high numbers of stromal B-cells were
characterized by relatively low presence of intraepithe-
lial CD3+ T-cells (Fig. 4 of the Online Resource 1).
As another example, we envision that the combination
of focal CD4+ T-cells in predominantly stromal local-
ization, along with CD8+ T-cell clusters in the neigh-
borhood of destroyed or disintegrating lobular epithe-
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lium could be a distinguishing feature. This is based
on the observation that this pattern was rarely present
in the 53 normal breast samples of the current study,
but repeatedly seen in an independent series of archival
prophylactic mastectomy samples [1] in patients with
BRCA1/2 germline mutations (see two representative
examples in Fig. 7 of the Online Resource 1). We pro-
pose such combined quantitative and spatial criteria to
refine differences between normal and pathological con-
ditions by large-scale image analysis.
4 Discussion
In this study, we described the distribution of immune
cell subpopulations in normal breast tissue with focus
on markers of growing relevance for oncoimmunology
(CD4, CD8, CD163) and integrate their spatial patterns
applying advanced image analysis. The high number
of CD8+ T-lymphocytes and their dependence on the
menstrual cycle and the use of oral contraceptives sug-
gest the permanent presence of a T-cell population re-
lated to immunosurveillance under control of hormonal
fluctuations. This can have implications for those di-
agnostic procedures where the nonmalignant compo-
nents of the iTME are evaluated, for example in dia-
betic mastopathy [40], sclerosing lymphocytic lobulitis
associated with autoimmune disease [17], and after pro-
phylactic mastectomy [19].
Using the published quantitative definitions [16] ac-
cepting that one lobule is sufficient to diagnose LLO in
an individual patient, more than 70% of patients in our
data set would qualify for LLO. At the level of individ-
ual lobules, we estimated that a number of at least 100
CD8+ lymphocytes are contained in 17.3% of all ROIs
that correspond to areas usually described as “repre-
sentative lobules” with 250–2500 epithelial cells, 50–100
CD8+ lymphocytes are contained in further 27.6%. As-
suming that CD8+ lymphocytes are only a subset of all
included lymphocytes, more than a quarter of normal
lobules show LLO based on the definition “100 lym-
phocytes” [19]. Applying the definition of “more than
50 mononuclear cells per lobule” for moderate and 100
for severe LLO [16] to the CD8 and CD163 popula-
tion about 81% of the normal lobules would show LLO.
Since CD8+ and CD163+ cells are only a small subset of
mononuclear cells, this is an underestimation. Based on
the definition “at least four lymphocytes between the
adjacent acini” [8], we estimated that about 20% of lob-
ules in reduction mammoplasty samples would qualify
for LLO. It should be questioned whether it is useful to
define a potentially pathological condition like LLO in
such a high percentage of asymptomatic women with-
out clinical and histopathological abnormalities. Rather
than claiming a generally applicable LLO definition, we
propose to use conventional quantitative assessment to
identify cases requiring further analysis, and to con-
sider phenotypes, relative quantities, and localization
of immune cells in order to contribute to a refinement
of future LLO definitions. These might be different in
various pathological conditions due to the individual
underlying pathogenic mechanisms.
Reduction mammoplasty samples from patients con-
sidered healthy by all medical standards at the time of
the surgery are strong evidence, but limitations of the
approach should be mentioned. First, we cannot ex-
clude that single patients may have been affected by
breast cancer during their life after surgery. Second, it
has been discussed that breast tissue from reduction
mammoplasty may not be entirely representative for
the “normal” female population with regard to slightly
increased incidence of nonmalignant, non-proliferative
lesions [9] and the occasional occurrence of premalig-
nant lesions as described in a series from Brazil [32].
However, it can be considered the best type of tissue
available for large-scale analysis, as opposed to needle
biopsy specimens [9] that may miss some of the hetero-
geneity present in the iTME of breast glands (Fig. 2).
We conclude that our study provides a solid approxima-
tion towards defining the range of normal immune cell
presence. This is useful for future comparisons with dif-
ferent pathological conditions such as LLO in the con-
text of genetic predisposition or manifest breast cancer.
In current practice, the evaluation of the inflamma-
tory microenvironment in breast cancer [35,10] is based
on “Tumor infiltrating lymphocytes” (TILs) within the
tumor mass and does neither consider the hormonal
status of the patients (cycle phase, menopause, medi-
cation) nor the adjacent non-neoplastic tissue. Our re-
sults indicate that cycle phase and use of oral contra-
ceptive therapy could potentially be relevant for evalu-
ation, particularly in newly diagnosed patients without
previous therapy-related effects. While changes up to
2-fold as observed in healthy patients may be a minor
aspect for evaluation of solid tumor masses, where more
than 60% of the stromal compartment can be TILs [35,
10], the patient history may be much more relevant for
inflammatory changes in adjacent non-neoplastic tis-
sue. For example, experience from colon cancer suggests
that lymphocyte subsets at the invasive edge of tumors
are more relevant for prognosis than the central tumor
mass [14]. In this regard, our approach has the potential
to support improvements of prognostic precision in the
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emerging era of oncoimmunology, for example, to eval-
uate inflammation close to benign precursor lesions [16,
18,21,6,26] or in preexisting glandular tissue adjacent
to cancer areas of small early-stage tumors, where tu-
mor is frequently closely related to non-neoplastic pre-
existing tissue.
In summary, this work provides an important proof-
of-concept that automated recognition of ROIs is pos-
sible in breast tissue and that large-scale image anal-
ysis of WSIs provides an added value by increasing
reproducibility and observer independence. We antic-
ipate a growing demand for immune cell evaluation
beyond semi-quantitative scoring of TILs, such that
technologies in immunoscoring for effector T-cells [10]
and alternatively activated macrophages [39] will be-
come increasingly important. As a long-term impact,
further development of our approach will pave the way
for broader applications of digital pathology in breast
cancer biomarker evaluation, including automated de-
tection of tumor, stroma, invasive edge, and adjacent
normal tissues as relevant ROIs.
Online Resource 1
OnlineResource1.pdf contains additional information on
methods as well as a collection of additional figures.
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